Research on Long-Term Risk of VTE Sheds Light on Managing Chronic Condition

July 31, 2019 | Strategic Insights for Health System


‚ÄčWhat's the news. For patients with a first unprovoked venous thromboembolism (VTE) who completed at least three months of anticoagulant treatment, the risk of recurrence rose over time, reaching a 10% likelihood in the first year after treatment and 36% at 10 years, a July 24, 2019, study published in the BMJ says.

Access Full Content

Contact us today at 610.825.6000.